Regencell bioscience holdings limited included in the msci world micro cap index

Hong kong--(business wire)--regencell bioscience holdings limited (nasdaq: rgc) (“regencell” or the “company”), an early-stage bioscience company focuses on the research, development and commercialization of tcm for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people's immune system, announced that the ordinary shares of the company will be added to the msci world micro cap index on november 30, 2021 after the close of market (effective d
RGC Ratings Summary
RGC Quant Ranking